Kioumarce Yazdani MD in Huntingtown, Maryland

Medical School: Sorry, his university is not listed
Graduation Year: 1967
The Primary Medical Specialty for Kioumarce Yazdani MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 57
PAC (PECOS ID)#: 6901834076
NPI #: 1104810175
NPI Created On: 09/07/2005
NPI Last Updated Listed as: 07/24/2008
Primary Taxonomy Code: 207RC0000X
License Number:
D0017168
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• CareFirst BlueChoice, Inc.
• Group Hospitalization and Medical Services Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English,Farsi, Persian, Farsi, Persian.

Services and Procedures include:

1. Vaccine for influenza for injection into muscle
2. Routine ekg using at least 12 leads including interpretation and report
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
4. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
5. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
6. Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
7. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
8. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
9. Established patient office or other outpatient visit, typically 15 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Established patient office or other outpatient, visit typically 40 minutes
14. Established patient office or other outpatient, visit typically 40 minutes
15. Administration of influenza virus vaccine
16. Injection, methylprednisolone acetate, 80 mg